Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions
NCT ID: NCT06557005
Last Updated: 2025-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1320 participants
INTERVENTIONAL
2025-05-23
2028-05-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bridging the Gap From Postpartum to Primary Care
NCT05543265
Preconception and Pregnancy Obesity Treatment and Prevention Among Women With a History of Depression
NCT03053323
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
NCT05884190
Promoting Health in Pregnancy and Postpartum
NCT02260518
The Mom and Infant Outcomes (MOMI) Study
NCT06277661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Routine Care
Routine postpartum care
No interventions assigned to this group
Facilitated Transition Group
The intervention is integrated into routine inpatient postpartum care and includes the following components: default PCP visit scheduling, tailored nudge messages to patients, ongoing care recommendations sent to the PCP, and a summary of recommendations after pregnancy given to the patient.
Facilitated Transition to Primary Care
The intervention includes default PCP visit scheduling, tailored nudge messages to patients, ongoing care recommendations sent to the PCP, and a summary of recommendations after pregnancy given to the patient.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Facilitated Transition to Primary Care
The intervention includes default PCP visit scheduling, tailored nudge messages to patients, ongoing care recommendations sent to the PCP, and a summary of recommendations after pregnancy given to the patient.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnant with a live fetus or delivered a live-born neonate ≥24 weeks of gestation, based on the clinical estimate of gestational age
* If postpartum, has a neonate that is currently living at the time of enrollment
* Has one or more of the following conditions listed in the "Problem List," "Medical History," or clinical notes during prenatal, intrapartum, or postpartum encounters in the EHR (or in the case of BMI, the patient's anthropometric measurements):
* Chronic or essential hypertension
* Hypertensive disorders related to pregnancy (e.g., pre-eclampsia)
* Type 1 or 2 diabetes (i.e., pre-existing diabetes)
* Gestational diabetes
* Class II Obesity (pre-pregnancy body mass index ≥35 kg/m2; or if pre-pregnancy body mass index is not known, a first trimester BMI of ≥35 kg/m2)
* Depression or anxiety disorder
* Has a primary care clinician listed in the patient's medical record
* Has access to or agrees to be enrolled in the electronic health record patient portal and consents to be contacted via these modalities
* Able to read/speak English or Spanish language
* Is age ≥18 years old
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Harvard School of Public Health (HSPH)
OTHER
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark Clapp, MD MPH
Physician Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark A Clapp, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024P002210
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.